Annuncio • Jun 30
Henan Jindan Lactic Acid Technology Co.,Ltd. to Report First Half, 2026 Results on Aug 25, 2026 Henan Jindan Lactic Acid Technology Co.,Ltd. announced that they will report first half, 2026 results on Aug 25, 2026 Declared Dividend • Jun 05
Dividend increased to CN¥0.10 Dividend of CN¥0.10 is 100% higher than last year. Ex-date: 8th June 2026 Payment date: 8th June 2026 Dividend yield will be 0.6%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (21% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 56 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to decline by 77% to shift the payout ratio to a potentially unsustainable range, which is more than the 5.5% EPS decline seen over the last 5 years. Board Change • May 20
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 7 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Long Yu was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Annuncio • Apr 21
Henan Jindan Lactic Acid Technology Co.,Ltd., Annual General Meeting, May 12, 2026 Henan Jindan Lactic Acid Technology Co.,Ltd., Annual General Meeting, May 12, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Dancheng County, Henan China Annuncio • Mar 31
Henan Jindan Lactic Acid Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 28, 2026 Henan Jindan Lactic Acid Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026 Annuncio • Dec 31
Henan Jindan Lactic Acid Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 22, 2026 Henan Jindan Lactic Acid Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 22, 2026 Annuncio • Sep 30
Henan Jindan Lactic Acid Technology Co.,Ltd. to Report Q3, 2025 Results on Oct 28, 2025 Henan Jindan Lactic Acid Technology Co.,Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025 Annuncio • Jul 02
Henan Jindan Lactic Acid Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 22, 2025 Henan Jindan Lactic Acid Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 22, 2025 Annuncio • Apr 22
Henan Jindan Lactic Acid Technology Co.,Ltd. Proposes Final Cash Dividend for the Year 2024 Henan Jindan Lactic Acid Technology Co.,Ltd. proposed final cash dividend of CNY 0.50000000 per 10 shares (tax included) for the year 2024. Annuncio • Apr 21
Henan Jindan Lactic Acid Technology Co.,Ltd., Annual General Meeting, May 12, 2025 Henan Jindan Lactic Acid Technology Co.,Ltd., Annual General Meeting, May 12, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Dancheng County, Henan China Annuncio • Mar 31
Henan Jindan Lactic Acid Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 26, 2025 Henan Jindan Lactic Acid Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025 Annuncio • Jan 11
Henan Jindan Lactic Acid Technology Co.,Ltd. (SZSE:300829) announces an Equity Buyback for CNY 70 million worth of its shares. Henan Jindan Lactic Acid Technology Co.,Ltd. (SZSE:300829) announces a share repurchase program. Under the program, the company will repurchase up to CNY 70 million worth of its A shares. The repurchase price will not more than CNY 28.11 per Share. The repurchased shares will be used for employee stock ownership plan or equity incentives. The repurchases will be funded using company's own funds. The repurchase period will be not more than 12 months. Annuncio • Dec 31
Henan Jindan Lactic Acid Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 21, 2025 Henan Jindan Lactic Acid Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 21, 2025 New Risk • Oct 30
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 30% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 5.4% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Shareholders have been diluted in the past year (3.1% increase in shares outstanding). Reported Earnings • Oct 28
Third quarter 2024 earnings released: EPS: CN¥0.22 (vs CN¥0.23 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.22 (down from CN¥0.23 in 3Q 2023). Revenue: CN¥373.4m (up 8.2% from 3Q 2023). Net income: CN¥40.3m (down 5.4% from 3Q 2023). Profit margin: 11% (down from 12% in 3Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has fallen by 26% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥15.15, the stock trades at a trailing P/E ratio of 29.9x. Average trailing P/E is 31x in the Chemicals industry in China. Total loss to shareholders of 67% over the past three years. Annuncio • Sep 30
Henan Jindan Lactic Acid Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 28, 2024 Henan Jindan Lactic Acid Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 28, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥14.41, the stock trades at a trailing P/E ratio of 28.5x. Average trailing P/E is 29x in the Chemicals industry in China. Total loss to shareholders of 68% over the past three years. Reported Earnings • Aug 28
Second quarter 2024 earnings released: EPS: CN¥0.26 (vs CN¥0.20 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.26 (up from CN¥0.20 in 2Q 2023). Revenue: CN¥386.9m (down 2.4% from 2Q 2023). Net income: CN¥44.2m (up 20% from 2Q 2023). Profit margin: 11% (up from 9.3% in 2Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has fallen by 37% per year, which means it is performing significantly worse than earnings. Annuncio • Jun 29
Henan Jindan Lactic Acid Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 28, 2024 Henan Jindan Lactic Acid Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 28, 2024 New Risk • Jun 13
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.7x net interest cover). Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 1.5% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (3.1% increase in shares outstanding). Declared Dividend • Jun 01
Dividend reduced to CN¥0.10 Dividend of CN¥0.10 is 9.1% lower than last year. Ex-date: 4th June 2024 Payment date: 4th June 2024 Dividend yield will be 0.6%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (21% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 36 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to decline by 76% to shift the payout ratio to a potentially unsustainable range, which is more than the 7.3% EPS decline seen over the last 5 years. Annuncio • May 31
Henan Jindan Lactic Acid Technology Co.,Ltd. Announces 2023 Final Profit Distribution on A Shares, Payable on 04 June 2024 Henan Jindan Lactic Acid Technology Co.,Ltd. announced 2023 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 1.00000000. Record date is 03 June 2024. Ex-date is 04 June 2024. Payment date is 04 June 2024. New Risk • May 30
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.7x net interest cover). Earnings have declined by 1.5% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.9% average weekly change). Shareholders have been diluted in the past year (3.1% increase in shares outstanding). Valuation Update With 7 Day Price Move • May 06
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to CN¥20.64, the stock trades at a trailing P/E ratio of 43x. Average trailing P/E is 33x in the Chemicals industry in China. Total loss to shareholders of 52% over the past three years. Reported Earnings • Apr 22
Full year 2023 earnings released: EPS: CN¥0.47 (vs CN¥0.73 in FY 2022) Full year 2023 results: EPS: CN¥0.47 (down from CN¥0.73 in FY 2022). Revenue: CN¥1.42b (down 7.6% from FY 2022). Net income: CN¥85.2m (down 36% from FY 2022). Profit margin: 6.0% (down from 8.6% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has fallen by 29% per year, which means it is performing significantly worse than earnings. Valuation Update With 7 Day Price Move • Apr 17
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to CN¥13.73, the stock trades at a trailing P/E ratio of 23x. Average trailing P/E is 26x in the Chemicals industry in China. Total loss to shareholders of 64% over the past three years. Annuncio • Mar 30
Henan Jindan Lactic Acid Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 25, 2024 Henan Jindan Lactic Acid Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 25, 2024 Valuation Update With 7 Day Price Move • Mar 19
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥17.97, the stock trades at a trailing P/E ratio of 27.3x. Average trailing P/E is 31x in the Chemicals industry in China. Total loss to shareholders of 54% over the past three years. Annuncio • Mar 09
Henan Jindan Lactic Acid Technology Co.,Ltd. (SZSE:300829) announces an Equity Buyback for CNY 60 million worth of its shares. Henan Jindan Lactic Acid Technology Co.,Ltd. (SZSE:300829) announces a share repurchase program. Under the program, the company will repurchase up to CNY 60 million worth of its shares. The repurchase price will not more than CNY 22.16 per Share. The repurchased shares will be used for employee stock ownership plan or equity incentives. The repurchases will be funded using company's own funds. The repurchase period will be not more than 12 months. Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥15.07, the stock trades at a trailing P/E ratio of 22.9x. Average trailing P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 77% over the past three years. Annuncio • Dec 30
Henan Jindan Lactic Acid Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 22, 2024 Henan Jindan Lactic Acid Technology Co.,Ltd. announced that they will report fiscal year 2023 results on Apr 22, 2024 Reported Earnings • Oct 27
Third quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.11 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.23 (up from CN¥0.11 in 3Q 2022). Revenue: CN¥345.2m (down 2.0% from 3Q 2022). Net income: CN¥42.6m (up 115% from 3Q 2022). Profit margin: 12% (up from 5.6% in 3Q 2022). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 26% per year, which means it is performing significantly worse than earnings. New Risk • Sep 06
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 34% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. This is currently the only risk that has been identified for the company. Reported Earnings • Aug 29
Second quarter 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.25 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.20 (down from CN¥0.25 in 2Q 2022). Revenue: CN¥396.5m (down 7.6% from 2Q 2022). Net income: CN¥36.7m (down 18% from 2Q 2022). Profit margin: 9.3% (down from 11% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has fallen by 34% per year, which means it is performing significantly worse than earnings. Annuncio • May 25
Henan Jindan Lactic Acid Technology Co.,Ltd. Implements Final Profit Distribution Plan of A Shares for 2022, Payable on 31 May 2023 Henan Jindan Lactic Acid Technology Co.,Ltd. announced 2022 final profit distribution plan to be implemented (A shares) as Cash dividend/10 shares (tax included): CNY 1.10000000. Record date: 30 May 2023, Ex-date: 31 May 2023, Payment date: 31 May 2023. Net cash dividend/10 shares after tax: CNY 0.99000000 (CNY 1.10000000 - CNY 0.11000000). Net cash dividend/10 shares after tax: CNY 0.99000000 (CNY 1.10000000- CNY 0.11000000). Reported Earnings • Apr 22
Full year 2022 earnings released: EPS: CN¥0.73 (vs CN¥0.73 in FY 2021) Full year 2022 results: EPS: CN¥0.73 (in line with FY 2021). Revenue: CN¥1.53b (up 6.7% from FY 2021). Net income: CN¥132.2m (flat on FY 2021). Profit margin: 8.6% (down from 9.2% in FY 2021). The decrease in margin was driven by higher expenses. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Oct 31
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥21.20, the stock trades at a trailing P/E ratio of 29.6x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 47% over the past year. Reported Earnings • Oct 25
Third quarter 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.23 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.11 (down from CN¥0.23 in 3Q 2021). Revenue: CN¥352.1m (flat on 3Q 2021). Net income: CN¥19.8m (down 52% from 3Q 2021). Profit margin: 5.6% (down from 12% in 3Q 2021). Reported Earnings • Aug 17
Second quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.23 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.25 (up from CN¥0.23 in 2Q 2021). Revenue: CN¥429.1m (up 27% from 2Q 2021). Net income: CN¥45.0m (up 6.0% from 2Q 2021). Profit margin: 11% (down from 13% in 2Q 2021). The decrease in margin was driven by higher expenses. Reported Earnings • Apr 28
First quarter 2022 earnings released: EPS: CN¥0.24 (vs CN¥0.16 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.24 (up from CN¥0.16 in 1Q 2021). Revenue: CN¥377.6m (up 18% from 1Q 2021). Net income: CN¥43.2m (up 55% from 1Q 2021). Profit margin: 11% (up from 8.7% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 44%, compared to a 43% growth forecast for the industry in China. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Apr 03
Full year 2021 earnings released: EPS: CN¥0.73 (vs CN¥0.72 in FY 2020) Full year 2021 results: EPS: CN¥0.73 (up from CN¥0.72 in FY 2020). Revenue: CN¥1.44b (up 40% from FY 2020). Net income: CN¥132.7m (up 11% from FY 2020). Profit margin: 9.2% (down from 12% in FY 2020). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 32%, compared to a 48% growth forecast for the industry in China. Valuation Update With 7 Day Price Move • Oct 29
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CN¥38.66, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 19% over the past year. Reported Earnings • Oct 23
Third quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.21 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥355.0m (up 43% from 3Q 2020). Net income: CN¥40.8m (up 8.0% from 3Q 2020). Profit margin: 12% (down from 15% in 3Q 2020). The decrease in margin was driven by higher expenses. Reported Earnings • Aug 28
Second quarter 2021 earnings released: EPS CN¥0.23 (vs CN¥0.17 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥338.9m (up 26% from 2Q 2020). Net income: CN¥42.4m (up 51% from 2Q 2020). Profit margin: 13% (up from 10% in 2Q 2020). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Apr 26
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥70.50, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 20x in the Chemicals industry in China. Reported Earnings • Apr 20
Full year 2020 earnings released: EPS CN¥1.16 (vs CN¥1.36 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: CN¥1.03b (up 17% from FY 2019). Net income: CN¥119.6m (up 3.8% from FY 2019). Profit margin: 12% (down from 13% in FY 2019). The decrease in margin was driven by higher expenses. Reported Earnings • Mar 11
Full year 2020 earnings released: EPS CN¥1.15 (vs CN¥1.36 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: CN¥1.03b (up 18% from FY 2019). Net income: CN¥118.7m (up 3.1% from FY 2019). Profit margin: 12% (down from 13% in FY 2019). The decrease in margin was driven by higher expenses. Analyst Estimate Surprise Post Earnings • Mar 11
Revenue beats expectations Revenue exceeded analyst estimates by 5.7%. Over the next year, revenue is forecast to grow 37%, compared to a 52% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Mar 01
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥84.08, the stock is trading at a trailing P/E ratio of 65.5x, down from the previous P/E ratio of 79.4x. This compares to an average P/E of 36x in the Chemicals industry in China. Is New 90 Day High Low • Feb 26
New 90-day low: CN¥90.15 The company is down 4.0% from its price of CN¥93.80 on 27 November 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period. Is New 90 Day High Low • Jan 13
New 90-day high: CN¥112 The company is up 38% from its price of CN¥81.31 on 16 October 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period. Is New 90 Day High Low • Dec 03
New 90-day high: CN¥111 The company is up 3.0% from its price of CN¥108 on 04 September 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 4.0% over the same period. Reported Earnings • Oct 28
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥124.0m, up 21% from the prior year. Total revenue was CN¥958.3m over the last 12 months, up 41% from the prior year. Is New 90 Day High Low • Oct 25
New 90-day low: CN¥75.00 The company is down 2.0% from its price of CN¥76.22 on 27 July 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. Valuation Update With 7 Day Price Move • Oct 19
Market pulls back on stock over the past week After last week's 20% share price decline to CN¥78.73, the stock is trading at a trailing P/E ratio of 57x, down from the previous P/E ratio of 70.9x. This compares to an average P/E of 40x in the Chemicals industry in China.